Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

USA - NASDAQ:MDB - US60937P1066 - Common Stock

319.13 USD
-4.46 (-1.38%)
Last: 9/23/2025, 3:29:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MDB. MDB was compared to 87 industry peers in the IT Services industry. No worries on liquidiy or solvency for MDB as it has an excellent financial health rating, but there are worries on the profitability. MDB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MDB had positive earnings in the past year.
In the past year MDB had a positive cash flow from operations.
In the past 5 years MDB always reported negative net income.
In multiple years MDB reported negative operating cash flow during the last 5 years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.22%, MDB is doing worse than 63.22% of the companies in the same industry.
The Return On Equity of MDB (-2.67%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.22%
ROE -2.67%
ROIC N/A
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K

1.3 Margins

MDB has a Gross Margin of 72.33%. This is amongst the best in the industry. MDB outperforms 88.51% of its industry peers.
In the last couple of years the Gross Margin of MDB has remained more or less at the same level.
MDB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MDB has more shares outstanding
MDB has a better debt/assets ratio than last year.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

MDB has an Altman-Z score of 26.89. This indicates that MDB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MDB (26.89) is better than 97.70% of its industry peers.
MDB has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.14, MDB belongs to the top of the industry, outperforming 90.80% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that MDB is not too dependend on debt financing.
MDB has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. MDB outperforms 81.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Altman-Z 26.89
ROIC/WACCN/A
WACC9.15%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MDB has a Current Ratio of 5.70. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MDB (5.70) is better than 90.80% of its industry peers.
A Quick Ratio of 5.70 indicates that MDB has no problem at all paying its short term obligations.
MDB has a better Quick ratio (5.70) than 90.80% of its industry peers.
Industry RankSector Rank
Current Ratio 5.7
Quick Ratio 5.7
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

7

3. Growth

3.1 Past

MDB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.53%, which is quite impressive.
The Revenue has grown by 21.90% in the past year. This is a very strong growth!
Measured over the past years, MDB shows a very strong growth in Revenue. The Revenue has been growing by 36.61% on average per year.
EPS 1Y (TTM)46.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)21.9%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%23.7%

3.2 Future

MDB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.14% yearly.
MDB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.15% yearly.
EPS Next Y-14.29%
EPS Next 2Y0.84%
EPS Next 3Y14.27%
EPS Next 5Y16.14%
Revenue Next Year19.03%
Revenue Next 2Y17.86%
Revenue Next 3Y17.75%
Revenue Next 5Y17.15%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 71.88, the valuation of MDB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MDB is on the same level as its industry peers.
MDB is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 85.99 indicates a quite expensive valuation of MDB.
MDB's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, MDB is valued quite expensively.
Industry RankSector Rank
PE 71.88
Fwd PE 85.99
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as MDB.
Industry RankSector Rank
P/FCF 108.23
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as MDB's earnings are expected to grow with 14.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.84%
EPS Next 3Y14.27%

More info and screens

0

5. Dividend

5.1 Amount

MDB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (9/23/2025, 3:29:02 PM)

319.13

-4.46 (-1.38%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)12-08 2025-12-08/amc
Inst Owners88.13%
Inst Owner Change-15.43%
Ins Owners0.82%
Ins Owner Change0.81%
Market Cap25.96B
Analysts81.86
Price Target332.67 (4.24%)
Short Float %8.42%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.75%
Min EPS beat(2)49.42%
Max EPS beat(2)50.09%
EPS beat(4)4
Avg EPS beat(4)63.33%
Min EPS beat(4)49.42%
Max EPS beat(4)87.64%
EPS beat(8)8
Avg EPS beat(8)61.79%
EPS beat(12)12
Avg EPS beat(12)143.59%
EPS beat(16)16
Avg EPS beat(16)136.92%
Revenue beat(2)2
Avg Revenue beat(2)4.38%
Min Revenue beat(2)2.96%
Max Revenue beat(2)5.81%
Revenue beat(4)4
Avg Revenue beat(4)4.64%
Min Revenue beat(4)2.96%
Max Revenue beat(4)5.81%
Revenue beat(8)8
Avg Revenue beat(8)4.11%
Revenue beat(12)12
Avg Revenue beat(12)4.98%
Revenue beat(16)16
Avg Revenue beat(16)5.68%
PT rev (1m)15.53%
PT rev (3m)16.63%
EPS NQ rev (1m)10.7%
EPS NQ rev (3m)10.57%
EPS NY rev (1m)0%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)2.26%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)2.81%
Revenue NY rev (3m)2.86%
Valuation
Industry RankSector Rank
PE 71.88
Fwd PE 85.99
P/S 11.71
P/FCF 108.23
P/OCF 96.16
P/B 8.82
P/tB 9.58
EV/EBITDA N/A
EPS(TTM)4.44
EY1.39%
EPS(NY)3.71
Fwd EY1.16%
FCF(TTM)2.95
FCFY0.92%
OCF(TTM)3.32
OCFY1.04%
SpS27.26
BVpS36.17
TBVpS33.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -2.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.33%
FCFM 10.82%
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
F-Score7
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.14
Debt/EBITDA N/A
Cap/Depr 96.16%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.7
Quick Ratio 5.7
Altman-Z 26.89
F-Score7
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)51.1%
Cap/Depr(5y)46.86%
Cap/Sales(3y)0.8%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y-14.29%
EPS Next 2Y0.84%
EPS Next 3Y14.27%
EPS Next 5Y16.14%
Revenue 1Y (TTM)21.9%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%23.7%
Revenue Next Year19.03%
Revenue Next 2Y17.86%
Revenue Next 3Y17.75%
Revenue Next 5Y17.15%
EBIT growth 1Y42.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.68%
EBIT Next 3Y34.89%
EBIT Next 5Y30.13%
FCF growth 1Y430.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y456.09%
OCF growth 3Y178.14%
OCF growth 5YN/A